Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 5 | 2019 | 382 | 1.960 |
Why?
|
| Intestinal Mucosa | 5 | 2016 | 765 | 1.420 |
Why?
|
| Extracellular Traps | 2 | 2019 | 8 | 1.170 |
Why?
|
| Dysbiosis | 3 | 2016 | 115 | 1.060 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 259 | 0.940 |
Why?
|
| Escherichia coli Infections | 3 | 2016 | 190 | 0.900 |
Why?
|
| Colitis | 5 | 2015 | 151 | 0.730 |
Why?
|
| Annexin A1 | 2 | 2012 | 5 | 0.710 |
Why?
|
| Escherichia coli | 2 | 2016 | 979 | 0.680 |
Why?
|
| Citrobacter rodentium | 4 | 2015 | 9 | 0.670 |
Why?
|
| Colitis, Ulcerative | 2 | 2012 | 210 | 0.630 |
Why?
|
| Calcitriol | 2 | 2015 | 82 | 0.590 |
Why?
|
| Vitamin D Deficiency | 2 | 2015 | 69 | 0.560 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2015 | 55 | 0.550 |
Why?
|
| Microbial Interactions | 1 | 2015 | 16 | 0.500 |
Why?
|
| Lactobacillus | 1 | 2015 | 43 | 0.500 |
Why?
|
| Gastrointestinal Tract | 3 | 2015 | 207 | 0.460 |
Why?
|
| NF-kappa B | 4 | 2023 | 460 | 0.450 |
Why?
|
| Gain of Function Mutation | 3 | 2023 | 103 | 0.430 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2014 | 261 | 0.430 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 230 | 0.410 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2011 | 303 | 0.410 |
Why?
|
| Lipoxins | 1 | 2012 | 12 | 0.410 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2024 | 106 | 0.400 |
Why?
|
| Probiotics | 2 | 2014 | 208 | 0.390 |
Why?
|
| Crohn Disease | 1 | 2015 | 281 | 0.390 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 286 | 0.380 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 7 | 0.360 |
Why?
|
| Autoimmune Diseases | 2 | 2023 | 248 | 0.360 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 4278 | 0.330 |
Why?
|
| Homeostasis | 2 | 2012 | 680 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 8 | 2016 | 4333 | 0.320 |
Why?
|
| Myeloblastin | 1 | 2007 | 19 | 0.290 |
Why?
|
| Cyclooxygenase 2 | 4 | 2012 | 158 | 0.290 |
Why?
|
| Inflammation | 4 | 2015 | 1393 | 0.280 |
Why?
|
| Mice | 10 | 2023 | 17494 | 0.270 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2019 | 201 | 0.270 |
Why?
|
| Transcription Factor RelB | 2 | 2023 | 6 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 261 | 0.270 |
Why?
|
| Animals | 15 | 2023 | 33670 | 0.240 |
Why?
|
| Bacterial Adhesion | 2 | 2016 | 108 | 0.240 |
Why?
|
| STAT1 Transcription Factor | 2 | 2022 | 67 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2378 | 0.230 |
Why?
|
| Actinobacteria | 2 | 2015 | 13 | 0.220 |
Why?
|
| Retinal Dystrophies | 1 | 2023 | 9 | 0.220 |
Why?
|
| Interferon Type I | 1 | 2023 | 107 | 0.220 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 252 | 0.210 |
Why?
|
| Osteochondrodysplasias | 1 | 2023 | 68 | 0.210 |
Why?
|
| Neonatal Screening | 1 | 2024 | 187 | 0.210 |
Why?
|
| HL-60 Cells | 2 | 2014 | 31 | 0.190 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2022 | 74 | 0.180 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2020 | 13 | 0.180 |
Why?
|
| Folic Acid | 1 | 2023 | 290 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2023 | 421 | 0.180 |
Why?
|
| Colon | 3 | 2012 | 347 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2024 | 479 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2012 | 870 | 0.170 |
Why?
|
| Microbiota | 2 | 2015 | 390 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 234 | 0.170 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2019 | 11 | 0.170 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2019 | 38 | 0.170 |
Why?
|
| Hydrogen Sulfide | 2 | 2009 | 11 | 0.160 |
Why?
|
| Pancreatic Elastase | 1 | 2019 | 14 | 0.160 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 46 | 0.150 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 96 | 0.150 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 37 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 44 | 0.140 |
Why?
|
| Drug Design | 2 | 2008 | 148 | 0.140 |
Why?
|
| Humans | 20 | 2024 | 121743 | 0.140 |
Why?
|
| Gastric Mucosa | 2 | 2011 | 480 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1295 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2826 | 0.130 |
Why?
|
| DNA | 1 | 2021 | 1607 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 3066 | 0.130 |
Why?
|
| Cell Line | 2 | 2014 | 2787 | 0.130 |
Why?
|
| Gammaproteobacteria | 1 | 2015 | 16 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 512 | 0.130 |
Why?
|
| Histones | 1 | 2019 | 522 | 0.120 |
Why?
|
| Electric Conductivity | 1 | 2015 | 89 | 0.120 |
Why?
|
| Cell Membrane Permeability | 1 | 2015 | 73 | 0.120 |
Why?
|
| Mouth Mucosa | 1 | 2015 | 51 | 0.120 |
Why?
|
| Bacteriological Techniques | 1 | 2015 | 90 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 268 | 0.120 |
Why?
|
| Mouth | 1 | 2015 | 55 | 0.120 |
Why?
|
| Male | 14 | 2024 | 59138 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 469 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2014 | 70 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2023 | 4504 | 0.110 |
Why?
|
| Cyclooxygenase 1 | 2 | 2010 | 40 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 82 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2014 | 175 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2017 | 508 | 0.110 |
Why?
|
| Receptors, Lipoxin | 1 | 2012 | 2 | 0.100 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2012 | 5 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2015 | 1102 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 1709 | 0.100 |
Why?
|
| Granulocytes | 1 | 2012 | 65 | 0.100 |
Why?
|
| Indomethacin | 2 | 2011 | 84 | 0.100 |
Why?
|
| Biodiversity | 1 | 2012 | 64 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 138 | 0.100 |
Why?
|
| Mucin-2 | 1 | 2011 | 35 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 146 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2014 | 375 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2011 | 63 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 476 | 0.090 |
Why?
|
| Jejunum | 1 | 2011 | 128 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2011 | 145 | 0.090 |
Why?
|
| Receptors, Prostaglandin | 1 | 2010 | 22 | 0.090 |
Why?
|
| Lipocalins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 673 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 458 | 0.090 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2010 | 56 | 0.090 |
Why?
|
| Intestines | 1 | 2014 | 571 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 306 | 0.080 |
Why?
|
| Chromatin | 1 | 2013 | 550 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2011 | 220 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2011 | 301 | 0.080 |
Why?
|
| Prostaglandin Antagonists | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3069 | 0.080 |
Why?
|
| Female | 8 | 2024 | 64492 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2011 | 252 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 60 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 614 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1788 | 0.080 |
Why?
|
| Neutrophil Activation | 1 | 2007 | 16 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 44 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2309 | 0.070 |
Why?
|
| Leukocytes | 1 | 2008 | 209 | 0.070 |
Why?
|
| Wound Healing | 1 | 2011 | 450 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 5749 | 0.070 |
Why?
|
| Adult | 4 | 2023 | 28623 | 0.070 |
Why?
|
| Pedigree | 2 | 2020 | 1575 | 0.070 |
Why?
|
| Cytokines | 1 | 2012 | 1274 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 654 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2008 | 438 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 751 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 278 | 0.060 |
Why?
|
| Rats, Wistar | 3 | 2011 | 356 | 0.060 |
Why?
|
| Ontario | 1 | 2024 | 65 | 0.060 |
Why?
|
| Lymphopenia | 1 | 2024 | 36 | 0.060 |
Why?
|
| Thyroid Epithelial Cells | 1 | 2023 | 1 | 0.060 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2023 | 2 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2023 | 41 | 0.060 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2023 | 20 | 0.060 |
Why?
|
| Thymus Gland | 1 | 2023 | 101 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2010 | 3221 | 0.050 |
Why?
|
| Electroretinography | 1 | 2023 | 115 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2677 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2007 | 898 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2023 | 141 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 121 | 0.050 |
Why?
|
| Phenotype | 2 | 2023 | 4207 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1673 | 0.050 |
Why?
|
| Fluorescein Angiography | 1 | 2023 | 137 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1434 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 3870 | 0.050 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2023 | 102 | 0.050 |
Why?
|
| Middle Aged | 2 | 2012 | 25388 | 0.050 |
Why?
|
| Heterozygote | 1 | 2023 | 679 | 0.050 |
Why?
|
| Feces | 2 | 2015 | 692 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3762 | 0.050 |
Why?
|
| Retinal Diseases | 1 | 2023 | 170 | 0.050 |
Why?
|
| Retina | 1 | 2023 | 457 | 0.040 |
Why?
|
| Rats | 3 | 2011 | 3653 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 533 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 476 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 510 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 756 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2023 | 377 | 0.040 |
Why?
|
| Biomarkers | 2 | 2022 | 2922 | 0.040 |
Why?
|
| Child | 3 | 2023 | 24035 | 0.040 |
Why?
|
| Alleles | 1 | 2022 | 1594 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2017 | 238 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 2533 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 834 | 0.030 |
Why?
|
| Tongue | 1 | 2015 | 27 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2023 | 13771 | 0.030 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 8 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 114 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 2536 | 0.030 |
Why?
|
| Adolescent | 2 | 2023 | 18879 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 15601 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 368 | 0.030 |
Why?
|
| Permeability | 1 | 2012 | 118 | 0.020 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2011 | 2 | 0.020 |
Why?
|
| Lansoprazole | 1 | 2011 | 22 | 0.020 |
Why?
|
| Naproxen | 1 | 2011 | 19 | 0.020 |
Why?
|
| Celecoxib | 1 | 2011 | 31 | 0.020 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2011 | 27 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8088 | 0.020 |
Why?
|
| Hematocrit | 1 | 2011 | 110 | 0.020 |
Why?
|
| Mucin 5AC | 1 | 2011 | 23 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2011 | 89 | 0.020 |
Why?
|
| Gastric Acid | 1 | 2011 | 50 | 0.020 |
Why?
|
| Omeprazole | 1 | 2011 | 98 | 0.020 |
Why?
|
| Stomach Ulcer | 1 | 2011 | 92 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2011 | 252 | 0.020 |
Why?
|
| Pinacidil | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 258 | 0.020 |
Why?
|
| Glyburide | 1 | 2009 | 22 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 8712 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2009 | 22 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2011 | 297 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 231 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 319 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 416 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 418 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 328 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1004 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 5906 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 12289 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1680 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 1983 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2007 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2794 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5995 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 11685 | 0.010 |
Why?
|